flumazenil has been researched along with Deafness in 3 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Safka Brozkova, D | 2 |
| Varga, L | 1 |
| Uhrova Meszarosova, A | 1 |
| Slobodova, Z | 1 |
| Skopkova, M | 1 |
| Soltysova, A | 1 |
| Ficek, A | 1 |
| Jencik, J | 1 |
| Lastuvkova, J | 1 |
| Gasperikova, D | 1 |
| Seeman, P | 2 |
| Paulasová Schwabová, J | 1 |
| Neupauerová, J | 1 |
| Sabová, J | 1 |
| Krůtová, M | 1 |
| Peřina, V | 1 |
| Trková, M | 1 |
| Laššuthová, P | 1 |
| Echaniz-Laguna, A | 1 |
| Degos, B | 1 |
| Bonnet, C | 1 |
| Latour, P | 1 |
| Hamadouche, T | 1 |
| Lévy, N | 1 |
| Leheup, B | 1 |
3 other studies available for flumazenil and Deafness
| Article | Year |
|---|---|
Variant c.2158-2A>G in MANBA is an important and frequent cause of hereditary hearing loss and beta-mannosidosis among the Czech and Slovak Roma population- evidence for a new ethnic-specific variant.
Topics: beta-Mannosidosis; Czech Republic; Deafness; Ethnicity; Hearing Loss; Humans; Minority Groups; Roma; | 2020 |
HMSN Lom in 12 Czech patients, with one unusual case due to uniparental isodisomy of chromosome 8.
Topics: Adult; Age of Onset; Cell Cycle Proteins; Charcot-Marie-Tooth Disease; Child; Child, Preschool; Chro | 2017 |
NDRG1-linked Charcot-Marie-Tooth disease (CMT4D) with central nervous system involvement.
Topics: Adolescent; Brain; Cell Cycle Proteins; Central Nervous System; Charcot-Marie-Tooth Disease; Deafnes | 2007 |